← Leaderboards
Kirill Ostanin
Navigen, Inc.
$2,281,127
Attributed
$2,281,127
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2013–15$2M$1.5M$1M$500K$0
'13
'14
'15
Funding mix
By agency
NIH$2,281,127 · 4
By mechanism
R44$1,502,644 · 1
U01$482,574 · 1
R43$295,909 · 2
Top collaborators
No co-investigators on record.
Most similar at Navigen, Inc.
Same institution · by research overlap
- Alan L Mueller$15,252,253
- Sutip Navankasattusas$2,784,365
Others in their field
Top investigators on “Natural Immunosuppression”
- Keri Hammel · The Emmes Company, Llc$39,738,903
- Joren C Madsen · Massachusetts General Hospital$34,789,357
- Ignacio E. Sanz · University Of Rochester$26,794,157
- Allan D. Kirk · Emory University$24,279,228
- Mohamed H Sayegh · University Of Pennsylvania$23,188,381
- Peter G Stock · University Of California San Francisco$21,880,153
Research focus
Natural ImmunosuppressionPharmaceutical ChemistryMetabolicMouse ModelPathway InteractionsInfiltrationInhibitor/AntagonistMediatingIn VitroMonomeric Gtp-Binding ProteinsLeukocytesPathogenesisImmuneImmune ResponseCytokineInflammatoryCytokine SignalingBlood VesselsCell ModelBaseDrug KineticsLeadInflammationPharmaceutical Preparations
Grant awards (8)
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr$755,418
R44 · FY2015 · AR · contact PI
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr$747,226
R44 · FY2014 · AR · contact PI
Targeting cytokine-mediated pathologies for neuroprotection in treatment of AMD$214,451
U01 · FY2014 · NS · contact PI
Targeting cytokine-mediated pathologies for neuroprotection in treatment of AMD$46,340
U01 · FY2014 · NS · contact PI
Targeting cytokine-mediated pathologies for neuroprotection in treatment of AMD$33,600
U01 · FY2014 · NS · contact PI
Targeting cytokine-mediated pathologies for neuroprotection in treatment of AMD$188,183
U01 · FY2013 · NS · contact PI
Identification of novel small molecule inhibitors of Arf6 for the treatment of va$150,640
R43 · FY2013 · EY · contact PI
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr$145,269
R43 · FY2013 · AR · contact PI